Frontier Wealth Management LLC historic quarter change: Foreign Stocks, Added
In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 7 quarters from 2014-12-31 to 2016-09-30, Frontier Wealth Management LLC opened 11 positions, added to 16, reduced 20 and sold out of 11.
- Q3 2016: Stock DEO; Country of operation —; Class SPON ADR NEW; Shares before 2,425.
- Q2 2016: Stock TEVA; Country of operation —; Class ADR; Shares before 13,160.
- Q2 2016: Stock BP; Country of operation —; Class SPONSORED ADR; Shares before 19,880.
- Q2 2016: Stock ULXXXX; Country of operation —; Class SPON ADR NEW; Shares before 6,700.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1548179), 7 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-10); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-13); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-17); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2014-12-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q3 2016 | DEO
DIAGEO P L C | | SPON ADR NEW | 2,425 | 2,500 | +75 | $274,000 | $290,000 | +$16,000 | 2016-11-14 |
|---|
| Q2 2016 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 13,160 | 18,160 | +5,000 | $704,000 | $912,000 | +$208,000 | 2016-08-10 |
|---|
| Q2 2016 | BP
BP PLC | | SPONSORED ADR | 19,880 | 20,853 | +973 | $600,000 | $740,000 | +$140,000 | 2016-08-10 |
|---|
| Q2 2016 | ULXXXX
UNILEVER PLC | | SPON ADR NEW | 6,700 | 7,300 | +600 | $303,000 | $350,000 | +$47,000 | 2016-08-10 |
|---|
| Q1 2016 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 3,160 | 13,160 | +10,000 | $207,000 | $704,000 | +$497,000 | 2016-05-13 |
|---|
| Q1 2016 | BP
BP PLC | | SPONSORED ADR | 18,993 | 19,880 | +887 | $594,000 | $600,000 | +$6,000 | 2016-05-13 |
|---|
| Q1 2016 | NOK
NOKIA CORP | | SPONSORED ADR | 20,119 | 22,921 | +2,802 | $141,000 | $135,000 | -$6,000 | 2016-05-13 |
|---|
| Q4 2015 | NVS
NOVARTIS A G | | SPONSORED ADR | 20,575 | 21,282 | +707 | $1,891,000 | $1,831,000 | -$60,000 | 2016-02-16 |
|---|
| Q4 2015 | NOK
NOKIA CORP | | SPONSORED ADR | 15,749 | 20,119 | +4,370 | $107,000 | $141,000 | +$34,000 | 2016-02-16 |
|---|
| Q3 2015 | CELJF
CELLCOM ISRAEL LTD | | SHS | 39,570 | 39,635 | +65 | $151,000 | $247,000 | +$96,000 | 2015-11-13 |
|---|
| Q3 2015 | NVS
NOVARTIS A G | | SPONSORED ADR | 18,386 | 20,575 | +2,189 | $1,808,000 | $1,891,000 | +$83,000 | 2015-11-13 |
|---|
| Q3 2015 | NOK
NOKIA CORP | | SPONSORED ADR | 15,249 | 15,749 | +500 | $104,000 | $107,000 | +$3,000 | 2015-11-13 |
|---|
| Q2 2015 | NVS
NOVARTIS A G | | SPONSORED ADR | 2,193 | 18,386 | +16,193 | $216,000 | $1,808,000 | +$1,592,000 | 2015-08-17 |
|---|
| Q2 2015 | CELJF
CELLCOM ISRAEL LTD | | SHS | 37,761 | 39,570 | +1,809 | $181,000 | $151,000 | -$30,000 | 2015-08-17 |
|---|
| Q2 2015 | BIDU
BAIDU INC | | SPON ADR REP A | 1,219 | 1,241 | +22 | $254,000 | $247,000 | -$7,000 | 2015-08-17 |
|---|
| Q1 2015 | BIDU
BAIDU INC | | SPON ADR REP A | 1,175 | 1,219 | +44 | $268,000 | $254,000 | -$14,000 | 2015-05-14 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |